Clinical Trials Browser

Completed × Breast × Clear all

NCT07545434 2026-04-22

Ν/Α

Breast Neoplasms

NCT01027416 2026-04-21

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Phase NA Completed

59 enrolled 10 charts

Breast Neoplasms

NCT03483012 2026-04-21

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

Phase 2 Completed

6 enrolled 19 charts

Breast Neoplasms

NCT04732598 2026-04-21

AMBITION

Phase 3 Completed

Breast Neoplasms

NCT05153187 2026-04-21

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

1,170 enrolled 16 charts

Breast Neoplasms

NCT05376527 2026-04-21

Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact

Phase 1 Completed

34 enrolled 18 charts

Breast Neoplasms, Vaccinia

NCT00006421 2026-04-20

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study

Breast Neoplasms

NCT00040222 2026-04-20

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT00043472 2026-04-20

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00475761 2026-04-20

Breast Mammogram and Tissue Study

Breast Neoplasms

NCT01251900 2026-04-20

BRCA Mutations in Latinas

Breast Neoplasms

NCT01574170 2026-04-17

METAL3

Phase 4 Completed

Breast Neoplasms

NCT02695121 2026-04-17

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

2,133,575 enrolled

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms

NCT03495115 2026-04-17

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Phase NA Completed

460 enrolled 4 charts

Breast Neoplasms

NCT06503393 2026-04-17

SENOVIE

Breast Neoplasms

NCT04085276 2026-04-16

TORCHLIGHT

Phase 3 Completed

Triple Negative Breast Neoplasms

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT04072952 2026-04-15

mBC

Phase 1/2 Completed

Breast Neoplasms

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT02311959 2026-04-14

MAPAM-01

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

NCT05609435 2026-04-14

Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Phase 2 Completed

180 enrolled 14 charts

Breast Neoplasms

NCT02705859 2026-04-13

Panther

Phase 1 Completed

HER2 Positive Breast Cancer

NCT02928978 2026-04-13

TBCRC042

Phase 2 Completed

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT03843346 2026-04-13

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

Breast Neoplasms

NCT05263362 2026-04-13

STARLINGS

Breast Carcinoma In Situ, Breast Neoplasms, Fibrosis

NCT05461430 2026-04-13

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT07162051 2026-04-13

A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT07512063 2026-04-13

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

Breast Neoplasms

NCT02390427 2026-04-09

Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT03832985 2026-04-09

Pediatric Reporting of Adult-Onset Genomic Results

Phase EARLY_PHASE1 Completed

162 enrolled 45 charts

BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hyperlipoproteinemia Type II, Hereditary Breast and Ovarian Cancer Syndrome

NCT03850873 2026-04-09

A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

Phase 1 Completed

Advanced Breast Cancer

NCT05399329 2026-04-09

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Breast Neoplasms

NCT07519668 2026-04-09

MAC004

Breast Neoplasms

NCT07521397 2026-04-09

ΗE_10R/22

Breast Neoplasms

NCT02595905 2026-04-08

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Phase 2 Completed

344 enrolled 11 charts

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04081779 2026-04-08

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Phase NA Completed

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT04796623 2026-04-08

A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

Phase 2 Completed

HR-positive, HER2-negative Advanced Breast Cancer

NCT05375461 2026-04-08

TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail

Phase 3 Completed

HR-positive,HER2-negative in Advanced Breast Cancer

NCT07307911 2026-04-08

Co-Pa-N

Phase 2 Completed

Breast Neoplasms

NCT00469339 2026-04-07

Risk Communication Within Mexican-American Families

BreastGastrointestinal

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus

NCT02129686 2026-04-07

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Phase NA Completed

Breast Neoplasms

NCT05365230 2026-04-07

A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Phase 4 Completed

Breast Neoplasms

NCT06020573 2026-04-07

Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection

Phase NA Completed

Margins of Excision, Breast Neoplasms

NCT06879522 2026-04-07

BCS_MAX

Phase NA Completed

Breast Cancer Survivor

NCT05064085 2026-04-06

Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT05607017 2026-04-06

Losartan in Prevention of Radiation-Induced Heart Failure

Phase EARLY_PHASE1 Completed

Radiation Fibrosis Syndrome, Breast Neoplasms